NEWS & MEDIA

ENDPOINT NEWS

ENDPOINT NEWS

4 MARCH 2024
Exclusive: Nocion raises $62M for different approach to chronic cough than Merck, GSK

Read more

ENDPOINT NEWS

ENDPOINT NEWS

4 JANUARY 2024
ARCH-backed immunology company HI-Bio raises $95M as it pushes toward late-stage studies

Read more

FORBES

FORBES

14 DECEMBER 2022
The Anti-Prediction Article: What Won’t Change In Healthcare In 2023?

Read more

CTECH

CTECH

27 NOVEMBER 2022
Arkin Holdings: “I’m actually afraid we are not at the bottom yet” of the tech crisis

Read more

KRIYA

KRIYA

16 NOVEMBER 2022
Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio

Read more

FORBES

FORBES

18 SEPTEMBER 2022
Kamari Pharma Raises $8 Million from the Sino-Israeli GIBF2 Fund

Read more

GlobeNewswire

GlobeNewswire

16 AUGUST 2022
Bluejay Therapeutics raises $41 million in Series B round to drive clinical trials in chronic hepatitis

Read more

CTECH

CTECH

04 APRIL 2022
Arkin Holdings is going all-in on digital health

Read more

CALCALIST

CALCALIST

27 OCTOBER 2021
Arkin Holdings raises $270 million for new biotech fund

Read more

GlobeNewswire

GlobeNewswire

29 APRIL 2021
Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering

Read more

CALCALIST

CALCALIST

28 JANUARY 2021
Arkin Holdings turns focus to digital health, eyeing investments in early-stage startups

Read more

PR NEWSWIRE

PR NEWSWIRE

6 May 2020
PTC Therapeutics to Acquire Censa Pharmaceuticals

Read more

Business Wire

Business Wire

April 15 2020
UroGen Pharma Receives U.S. FDA Expedited Approval for Jelmyto™, the First and Only Non-Surgical Treatment for Patients with Low-Grade Upper Tract Urothelial Cancer

Read more

Fierce Biotech

Fierce Biotech

April 8 2020
Keros upsizes IPO, raising $96M for blood and musculoskeletal trials

Read more

Nasdaq

Nasdaq

April 7 2020
Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range

Read more

Fierce Biotech

Fierce Biotech

25 March 2020
Redpin bags A round to advance Chantix-controlled gene therapies

Read more

Intrado GlobeNewswire

Intrado GlobeNewswire

11 March 2020
Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology Programs

Read more

Intrado GlobeNewswire

Intrado GlobeNewswire

11 March 2020
Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology Programs

Read more

Business Wire

Business Wire

9 MARCH 2020
Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio-Ventures II to Invest in Groundbreaking Pharma and Biotechnology Companies

Read more

CALCALIST

CALCALIST

3 FEBRUARY 2020
Arkin Bio Ventures adds migdal as anchor investor, bringing Arkin Holdings scope in BioMed to 1.4$ Billion

Read more

GLOBES

GLOBES

29 MAY 2019
Pi Therapeutics raises $19.7M for its new approach to curing cancer

Read more

CALCALIST

CALCALIST

2 MAY 2019
Edwardo Elstein sells 10% of Clal Insurance to Mori Arkin and Yakir Gabay

Read more

CISION PR NEWSWIRE

CISION PR NEWSWIRE

30 JULY 2018
BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia

Read more

GLOBES

GLOBES

12 MARCH 2018
Accelemd's Cogentix Medical aquired by Laborie for $242M

Read more

CISION PR NEWSWIRE

CISION PR NEWSWIRE

12 MARCH 2018
Cogentix Medical Enters Definitive Merger Agreement to be Acquired by Laborie Medical Technologies for a Purchase Price of $3.85 Per Share in Cash

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

05 FEBRUARY 2018
Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more

GLOBES

GLOBES

1 FEBRUARY 2018
Sol-Gel raises $75M

Read more

GLOBES

GLOBES

8 JANUARY 2018
Ladenburg Thalmann Financial Services initiated coverage on shares of Urogen Pharma

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

5 JANUARY 2018
Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

Read more

CALCALIST

CALCALIST

05 JANUARY 2018
Arkin Bioventures' Censa Pharmaceuticals raised $10M as part of a strategic long-term agreement with Retrophin

Read more

CALCALIST

CALCALIST

28 DECEMBER 2017
Merck, China’s WuXi AppTec and Mori Arkin to Launch Biotech Incubator in Israel

Read more

YAHOO FINANCE

YAHOO FINANCE

14 DECEMBER 2017
BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

Read more

GLOBES

GLOBES

7 MAY 2017
Urogen,Israeli urological cancer treatment developer raised 20% more than planned in Nasdaq IPO

Read more

CALCALIST

CALCALIST

5 MAY 2017
Urogen Pharma rasise $58M in Nasdaq IPO

Read more

GLOBES

GLOBES

19 JUNE 2016
Arkin & Phoenix set up $60m biomed investment fund

Read more

PR NEWSWIRE

PR NEWSWIRE

16 MAY 2016
Arkin Holdings and Primera Capital Lead an Investment of $13M in BioSight for an Innovative Treatment of Acute Leukemia

Read more

THE PE HUB NETWORK

THE PE HUB NETWORK

12 APRIL 2016
Israel’s Metabomed raises $18 mln for cancer-metabolism drugs

Read more

FORBES

FORBES

4 JANUARY 2016
Mori Arkin personal history on Forbes 2015 billionaire rankings

Read more

GLOBES

GLOBES

3 JANUARY 2016
Israeli shareholder Arkin rejects Mylan Perrigo bid

Read more

EQUILAR ATLAS

EQUILAR ATLAS

15 SEPTEMBER 2015
Moshe Arkin, Former Board Member at PERRIGO, bibliography

Read more

REUTERS

REUTERS

10 SEPTEMBER 2015
Israeli Perrigo shareholder slams Mylan’s $27 billion offer

Read more

GLOBES

GLOBES

28 JULY 2015
Merck buys cCAM Biotherapeutics for up to $605m

Read more

BIOSPACE

BIOSPACE

1 JUNE 2015
cCAM Biotherapeutics receives FDA approval to initiate phase One trial for CM-24, a novel immune checkpoint inhibitor for cancer immunotherapy

Read more

GLOBES

GLOBES

17 JULY 2014
Mori Arkin in talks to buy Sol-Gel

Read more

JEWISH BUSINESS NEWS

JEWISH BUSINESS NEWS

14 JULY 2014
Perrigo up for sale

Read more

STREETINSIDER.COM

STREETINSIDER.COM

16 NOVEMBER 2011
Arkin Holdings lowers stake in Perrigo (PRGO) to 5.35%

Read more

PR NEWSWIRE

PR NEWSWIRE

13 SEPTEMBER 2007
Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service

Read more

FINANCIAL TIMES

FINANCIAL TIMES

15 NOVEMBER 2004
Perrigo buys Israel’s Agis for $818m

Read more